Abstract-Chronic incubation with elevated D-glucose reduces adenosine transport in endothelial cells. In this study, exposure of human umbilical vein endothelial cells to 25 mmol/L D-glucose or 100 mol/L ATP, ATP-␥-S, or UTP, but not ADP or ␣,␤-methylene ATP, reduced adenosine transport with no change in transport affinity. Inhibition of transport by D-glucose, ATP, and ATP-␥-S was associated with reduced maximal binding, with no changes in the apparent dissociation constant for nitrobenzylthioinosine (NBMPR). A significant reduction (Ϸ60Ϯ10%, PϽ0.05; nϭ6) in the number of human equilibrative NBMPR-sensitive nucleoside transporters (hENT1s) per cell (1.8Ϯ0.1ϫ10 6 in 5 mmol/L D-glucose) and in hENT1 mRNA levels was observed in cells exposed to D-glucose or ATP-␥-S. Incubation with elevated D-glucose, but not with D-mannitol, increased the ATP release by 3Ϯ0.2-fold . The effects of D-glucose and nucleotides on the number and activity of hENT1 and hENT1 mRNA were blocked by reactive blue 2 (nonspecific P 2Y purinoceptor antagonist), suramin (G␣ s protein inhibitor), or hexokinase but not by pyridoxal phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (nonselective P 2 purinoceptor antagonist). Our findings demonstrate that inhibition of adenosine transport via hENT1 in endothelial cells cultured in 25 mmol/L D-glucose could be due to stimulation of P 2Y2 purinoceptors by ATP, which is released from these cells in response to D-glucose. This could be a mechanism to explain in part the vasodilatation observed in the early stages of diabetes mellitus or in response to D-glucose Key Words: endothelium Ⅲ adenosine Ⅲ nitric oxide Ⅲ glucose Ⅲ purinoceptors R emoval of extracellular adenosine is an essential step in the modulation of several of the biological actions of this endogenous nucleoside. 1-4 Plasma and tissue levels of adenosine are regulated by an efficient membrane transport mediated by the Na ϩ -independent, nitrobenzylthioinosine (NBMPR)-sensitive equilibrative nucleoside transporter (system es or ENT1) 3,4 in human vascular endothelium 5,6 and smooth muscle. 7, 8 Human ENT1 (hENT1) expression in Raji cells (a human B-lymphocyte cell line) is dependent on NO levels and the activity of protein kinase C (PKC). 9 Incubation of human umbilical vein endothelial cells (HUVECs) with 25 mmol/L D-glucose for 24 hours has been reported to reduce the NBMPR-sensitive adenosine transport associated with increased protein levels and the activity of endothelial NO synthase, intracellular Ca 2ϩ , PKC, and mitogen-activated protein kinases p42/p44 mapk . 6,10 Thus, hENT1 adenosine transporters could be expressed and modulated in HUVECs.
R emoval of extracellular adenosine is an essential step in the modulation of several of the biological actions of this endogenous nucleoside. [1] [2] [3] [4] Plasma and tissue levels of adenosine are regulated by an efficient membrane transport mediated by the Na ϩ -independent, nitrobenzylthioinosine (NBMPR)-sensitive equilibrative nucleoside transporter (system es or ENT1) 3, 4 in human vascular endothelium 5, 6 and smooth muscle. 7, 8 Human ENT1 (hENT1) expression in Raji cells (a human B-lymphocyte cell line) is dependent on NO levels and the activity of protein kinase C (PKC). 9 Incubation of human umbilical vein endothelial cells (HUVECs) with 25 mmol/L D-glucose for 24 hours has been reported to reduce the NBMPR-sensitive adenosine transport associated with increased protein levels and the activity of endothelial NO synthase, intracellular Ca 2ϩ , PKC, and mitogen-activated protein kinases p42/p44 mapk . 6, 10 Thus, hENT1 adenosine transporters could be expressed and modulated in HUVECs.
It has been reported that ATP inhibits dipyridamolesensitive adenosine transport in human pulmonary artery endothelium. 11 ATP also induces activation of PKC in endothelium from human umbilical vein, 12 bovine pulmonary artery, 13 and porcine aorta. 14, 15 Activation of P 2Y1 and P 2Y2 purinoceptors with ATP induced the phosphorylation of p42 mapk in the human endothelial cell line EAhy 926 16 and p42/p44 mapk in bovine aortic endothelium. 17 Therefore, the cellular effects of elevated D-glucose and activation of P 2Y purinoceptors could involve common signal transduction pathways in human endothelium.
We have investigated the involvement of P 2Y purinoceptors in the effect of elevated D-glucose on NBMPR-sensitive adenosine transport in cultures of HUVECs. We established that endothelial cells express the hENT1 isoform of nucleoside transporters and that incubation with 25 mmol/L D-glucose leads to inhibition of adenosine transport by a mechanism that involves the activation of P 2Y2 purinoceptors. In addition, elevated D-glucose diminished hENT1 mRNA levels, an effect mimicked by ATP and blocked by P 2Y antagonists. A preliminary account of the present study has been reported. 18 
Materials and Methods

Cell Culture
HUVECs were isolated from full-term normal pregnancies. Informed written consent was given from the hospital for the use of the umbilical cords. Cells isolated by collagenase (0.25 mg/mL) digestion were cultured (37°C, 5% CO 2 ) in medium 199 (M199) containing 5 mmol/L D-glucose, 20% bovine sera, 3.2 mmol/L L-glutamine, and 100 U/mL penicillin-streptomycin as described. 5 Twenty-four hours before an experiment, the incubation medium was changed to serum-free M199.
Adenosine Transport
Adenosine transport (4 Ci/mL) was measured as described. 5, 6 Cells were rinsed with warmed (37°C) Krebs solution containing (mmol/L) NaCl 131, KCl 5.6, NaHCO 3 6, 19 The kinetics of adenosine transport was measured in cells incubated with increasing concentrations of adenosine (0 to 500 mol/L, 5 seconds, 22°C) in Krebs solution. Tracer uptake was terminated by rinsing the monolayers (3 times) with 200 L ice-cold Krebs solution containing 10 mol/L NBMPR, and cell radioactivity was determined by liquid scintillation counting. 6, 8 Adenosine transport was also determined in cells exposed to the P 2Y antagonists reactive blue 2 (RB2, 0.1 to 100 nmol/L, 5 minutes or 24 hours), pyridoxal phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS, 0.1 to 100 nmol/L, 5 minutes or 24 hours), 20, 21 or the G␣ s protein inhibitor 8-(3-benzamido-4-methylbenzamido)-naphthalene-1,3,4-trisulfonic acid (suramin, 100 mol/L, 15 minutes or 24 hours). 22 Cells were then exposed to ATP (0.1 to 100 mol/L, 2 minutes), which is a nucleotide hydrolyzed by ectonucleotidases in human endothelium, 5 ATP-␥-S (0.1 to 100 mol/L, 2 minutes or 24 hours), which is a nonhydrolyzable analogue of ATP, 23 ADP (0.1 to 100 mol/L, 2 minutes), UTP (0.1 to 100 mol/L, 2 minutes), or ␣,␤-methylene ATP dilithium (␣,␤-MeATP, 0.1 to 100 mol/L, 2 minutes), which is a nonselective P 2X purinoceptor agonist, in the absence or presence of RB2, PPADS, or suramin. The effects of D-glucose and ATP were also assayed in cells preincubated (10 minutes or 24 hours) with 10 U/mL hexokinase. 24 Oligonucleotide primers were for hENT1 (sense) 5Ј-CATGAT-CTGCGCTATTGCCAGTGG-3Ј, hENT1 (antisense) 5Ј-AACCA-GGCATCGTGCTCGAAGACCA-3Ј, ␤-actin (sense) 5Ј-AACCGC-GAGAAGATGACCCAGATCATCTTT-3Ј, and ␤-actin (antisense) 5Ј-AGCAGCCGTGGCCATCTCTTGCTCGAAGTC-3Ј. Expected size products were 617 bp for hENT1 and 350 bp for ␤-actin.
NBMPR Binding
Materials
Newborn and fetal calf serum and agarose were from GIBCO Life Technologies. Collagenase type II (Clostridium histolyticum) was from Boehringer-Mannheim. Bradford protein reagent was from 
Statistical Analysis
Values are meanϮSEM, and n indicates different umbilical vein endothelial cell cultures with 3 to 6 replicate measurements per experiment. Statistical analyses were carried out on raw data by using the Peritz F multiple means comparison test. 26 A Student t test was applied for unpaired data, and a value of PϽ0.05 was considered statistically significant.
Results
Effect of D-Glucose on Adenosine Transport
We have reported that adenosine transport is inhibited by 10 nmol/L NBMPR or after incubation with 25 mmol/L D-glucose. 5, 6 In the present study, inhibition of NBMPRsensitive adenosine (10 mol/L) transport induced by 25 mmol/L D-glucose was blocked after incubation of the cells with RB2 or suramin but not PPADS ( Figure 1A ). Adenosine transport was also inhibited by ATP-␥-S or UTP; this effect was blocked by RB2 and suramin ( Figure 1B (Table 1) .
Effect of D-Glucose on NBMPR Binding
To determine whether the effects of D-glucose or ATP-␥-S on V max for adenosine transport were due to changes in the number of available adenosine transport sites, [ 3 H]NBMPR equilibrium binding was determined. 5 Table 2 
Discussion
The present study has established that HUVECs express the hENT1 transporter isoform and that inhibition of adenosine transport and of NBMPR binding by elevated D-glucose is associated with the activation of P 2Y2 purinoceptors. D-Glucose increased ATP release, and ATP, ATP-␥-S, or UTP, but not ADP or ␣,␤-MeATP, mimicked the inhibitory effects of D-glucose on adenosine transport and NBMPR binding. D-Glucose and ATP-␥-S also reduced the number of NBMPR-sensitive adenosine transporters and hENT1 mRNA levels; this effect was blocked by P 2Y purinoceptor antagonists. Adenosine transport was inhibited after the incubation of endothelial cells with 25 mmol/L D-glucose, confirming our previous observations in this cell type. 6 The inhibition of adenosine transport induced by D-glucose was blocked by the noncompetitive nonspecific P 2Y purinoceptor antagonist RB2 27, 28 and by the G␣ s protein inhibitor suramin 29, 30 but was unaffected by the nonselective P 2 purinoceptor antagonist PPADS, suggesting the involvement of P 2 purinoceptors in the effects of D-glucose. This could be due to ATP released from HUVECs in response to D-glucose, inasmuch as hexokinase, an ATP-degrading enzyme, 24 blocked the effect of D-glucose, and a 3-fold increase in the extracellular ATP level was detected in cells cultured in 25 mmol/L D-glucose compared with 5 mmol/L D-glucose (Ϸ35 pmol/mL). Basal ATP release from HUVECs is within the range of concentrations reported for this cell type (Ϸ40 pmol/mL). 25 Increased extracellular ATP derived from freshly dissociated or cultured endothelial cells has been shown to be a rapid response of cells to shear stress. 25, 31 Elevated D-glucose is a stress condition associated with metabolic alterations in vascular endothelium, 2,32,33 which could explain our findings of a higher extracellular ATP level.
TABLE 1. Effect of D-Glucose and Nucleotides on the Kinetic Parameters of Adenosine Transport in HUVECs
K m , mol/L V max , pmol ⅐ (10 6 Cells) Ϫ1 ⅐ s Ϫ1 K i , mol/
Involvement of P 2Y2 Purinoceptors in the Effect of D-Glucose on Adenosine Transport
HUVECs express at least 4 isoforms of P 2Y purinergic receptors, ie, P 2Y1 , P 2Y2 , P 2Y4 , and P 2Y6 , 34, 35 which exhibit different sensitivities for nucleotides and have been shown to mediate several cellular responses. 20,21,36 P 2Y2 and P 2Y4 purinoceptors are stimulated by ATP and UTP but are insensitive to ADP; P 2Y1 purinoceptors are stimulated by ATP and ADP but not by UTP; and P 2Y6 purinoceptors are stimulated by ADP but are insensitive to ATP or UTP. 21, 36 Thus, the inhibition of adenosine transport by high D-glucose, ATP, ATP-␥-S, or UTP could result from the activation of P 2Y2 or P 2Y4 purinoceptors in HUVECs. In addition, P 2Y2 , but not P 2Y1 , purinoceptors are stimulated by UTP; both purinoceptors are inhibited by RB2 20 ; and P 2Y4 purinoceptors are insensitive to inhibition by suramin. 22 Thus, P 2Y2 purinoceptors (the former P 2U receptors) 37 could be responsible for the inhibitory effect of D-glucose on adenosine transport in human endothelium. Because ␣,␤-MeATP, a general P 2X purinoceptor agonist, 20, 21 does not alter adenosine transport, it is suggested that these purinoceptors are not involved in the effect of elevated D-glucose on adenosine transport. 
Effect of D-Glucose on the Number of Adenosine Transporters
As reported, inhibition of adenosine transport by elevated D-glucose was associated with a reduced V max . 6 The effect of D-glucose was mimicked by ATP, ATP-␥-S, and UTP and blocked by RB2. These results were similar to changes induced by D-glucose, ATP, and ATP-␥-S in NBMPRbinding kinetics. The adenosine transport inhibitor NBMPR binds specifically to ENT1 (system es) transporters but is not transported itself; therefore, it can be used to estimate the surface density of ENT1 transporters in intact cells. 5, 38, 39 Thus, the inhibition of adenosine transport by elevated D-glucose and adenine or uridine nucleotides could be due to the reduced number rather than the activity of an existing pool of NBMPR-sensitive nucleoside transporters in the plasma membrane of HUVECs. This conjecture is supported by the finding that the number of adenosine transporters per cell (1.8Ϯ0.1ϫ0 6 transporters/cell) was significantly reduced by 25 mmol/L D-glucose (0.7Ϯ0.2ϫ0 6 transporters/cell, PϽ0.05; nϭ8) or 100 mol/L ATP-␥-S (0.5Ϯ0.1ϫ0 6 transporters/cell, PϽ0.04; nϭ12). However, the D-glucose-or ATP-␥-S-induced reduction in adenosine transport is not due to changes in the turnover number (ie, V max /number of transporters per cell) 5, 8 for adenosine (356Ϯ30 versus 324Ϯ45 or 439Ϯ75 adenosine molecules/transporter per second for 5 mmol/L versus 25 mmol/L D-glucose or 100 mol/L ATP-␥-S, respectively). These results are similar to previous reports showing a reduced number of adenosine membrane transporters without altering its turnover rate in human vascular endothelium 5 or smooth muscle cells 7 obtained from gestational diabetic pregnancies or in vascular smooth muscle cells exposed to human insulin. 8 Parallel experiments demonstrated a reduced hENT1 mRNA level in cells incubated with elevated D-glucose or ATP-␥-S for 24 hours. However, as expected, acute incubation of cells with elevated D-glucose or ATP (2 minutes) did not change hENT1 mRNA levels. Thus, possible explanations for a reduced number of hENT1 transporters are a lower transcription due to long exposure to D-glucose or an increased turnover rate of hENT1 transporters as described in other cell types. [1] [2] [3] The latter is supported by the finding of a reduced number of hENT1 transporters available at the plasma membrane after a brief (2-minute) exposure to elevated D-glucose (0.7Ϯ0.1ϫ10 6 transporters/cell, PϽ0.05; nϭ6) or ATP (0.5Ϯ0.2ϫ10 6 transporters/cell, PϽ0.05; nϭ6). Reduction in the number of adenosine transporters and hENT1 mRNA by D-glucose, ATP, and ATP-␥-S was blocked by RB2 but was unaltered by PPADS, indicating that activation of P 2Y purinoceptors leads to a lower uptake of adenosine by reducing hENT1 expression. hENT1 has been colocalized with A 1 nucleoside receptors in the human central nervous system, 4, 40, 41 suggesting a role of the hENT1-mediated transport process in the control of adenosinemediated biological actions. 2, 42, 43 Thus, expression of hENT1 transporters could be crucial in human pathological tissues in which high levels of D-glucose or adenosine nucleotides could modulate endothelial cell function, such as in diabetes mellitus. 2 The present results demonstrate that elevated D-glucose induced a reduction in adenosine transport in human umbilical vein endothelium by a mechanism that involves activation of P 2Y purinoceptors (possibly the P 2Y2 subtype). ATP may mediate the effect of elevated D-glucose, inasmuch as extracellular levels of this nucleotide are elevated in 25 mmol/L D-glucose, and ATP (and ATP-␥-S) mimicked the effects of D-glucose on adenosine transport and expression of hENT1. Thus, ATP could be playing an autocrine role in response to elevated D-glucose in HUVECs. The present study is the first report to demonstrate modulation of hENT1 expression and activity in human endothelium since the cloning of this transporter from human tissue. 3, 39, 42 Removal of extracellular adenosine is a key mechanism in the reduc- tion of extracellular levels of this nucleoside, modulating its biological actions on vascular cells. [1] [2] [3] [4] Adenosine has been shown to mediate vasodilatation via adenosine receptors by increasing NO synthesis from endothelial cells. 43, 44 Thus, a reduced removal of extracellular adenosine by the endothelium under pathological conditions in which plasma D-glucose is increased (such as in uncontrolled diabetes) could, in part, explain the early generalized vasodilatation observed in patients affected by this syndrome. 2 
